Back to search

Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin

Data up to Jan 2025

Published2000
Citations140
References42

Total Citations Per Year

Abstract

References (42)

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

1996 • 6,350 citations

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

1994 • 3,408 citations

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

1994 • 2,993 citations

The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure

1997 • 2,867 citations

急性心筋梗塞の疑いのある17187症例におけるストレプトキナーゼ静脈内投与,アスピリン経口投与,上記2つの併用または無処置の無作偽試験 ISIS-2

1988 • 2,760 citations

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

1988 • 2,740 citations

A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients

1989 • 1,209 citations

Randomized, Controlled Trial of Long-Term Moderate Exercise Training in Chronic Heart Failure

1999 • 1,100 citations

Secondary prevention of vascular disease by prolonged antiplatelet treatment

1988 • 962 citations

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1988 • 848 citations

Readmission After Hospitalization for Congestive Heart Failure Among Medicare Beneficiaries

1997 • 836 citations

Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine

1995 • 769 citations

Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction

1997 • 426 citations

Development of aspirin resistance in persons with previous ischemic stroke.

1994 • 412 citations

Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction

1997 • 301 citations

Acute Coronary Syndromes in the GUSTO-IIb Trial

1998 • 259 citations

Prevention of readmission in elderly patients with congestive heart failure

1993 • 257 citations

Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial

2000 • 245 citations

Incidence and Clinical Course of Thrombotic Thrombocytopenic Purpura Due to Ticlopidine Following Coronary Stenting

1999 • 235 citations

Aspirin response and failure in cerebral infarction.

1993 • 228 citations

Variation among Hospitals in Coronary-Angiography Practices and Outcomes after Myocardial Infarction in a Large Health Maintenance Organization

1996 • 183 citations

Economic Assessment of Low-Molecular-Weight Heparin (Enoxaparin) Versus Unfractionated Heparin in Acute Coronary Syndrome Patients

1998 • 176 citations

In-Hospital and One-Year Economic Outcomes After Coronary Stenting or Balloon Angioplasty

1995 • 174 citations

Clopidogrel

1997 • 155 citations

Epidemic of Cardiovascular Disease and Stroke: The Three Main Challenges

1999 • 132 citations

Clopidogrel Inhibition of Stent, Graft, and Vascular Thrombogenesis With Antithrombotic Enhancement by Aspirin in Nonhuman Primates

1998 • 126 citations

Invasive versus conservative strategies in unstable angina and non\NQ-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 trial

1998 • 119 citations

Acute Hemodynamic Interaction of Aspirin and Ticlopidine With Enalapril

1998 • 117 citations

Outcomes for Older Men and Women with Congestive Heart Failure

1997 • 116 citations

Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction

1998 • 115 citations

Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure

1998 • 75 citations

Choice of endpoints in antiplatelet trials

2000 • 65 citations

The Sequelae of Hospitalization for Congestive Heart Failure Among Older Adults

1997 • 65 citations

An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point.

1992 • 62 citations

Ultrastructural Studies of Platelet Aggregates From Human Subjects Receiving Clopidogrel and From a Patient With an Inherited Defect of an ADP-Dependent Pathway of Platelet Activation

1996 • 62 citations

Superiority of “triple” drug therapy in heart failure: insights from the PROVED and RADIANCE trials

1998 • 48 citations

Economics of Treating Heart Failure

1997 • 47 citations

Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina

1998 • 45 citations

Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: Study design of the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events post-acute cOroNary sYndromes (SYMPHONY) trial

1999 • 45 citations

Effect of aspirin and clopidogrel on platelet-dependent tissue factor expression in endothelial cells

1994 • 36 citations

Rehospitalization in surviving patients of out-of-hospital ventricular fibrillation (the CASCADE study)

1993 • 9 citations

Death, mode of death, morbidity and requirement for rehospitalization during 2 years after coronary artery bypass grafting in relation to preoperative ejection fraction

1996 • 9 citations

Cited By (0)

Loading...